Harrington P - Search Results

1

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.

Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, Kelemen LE, Goodman MT, Bandera EV, Terry KL, Schoof N, Eng KH, Clay A, Singh PK, Joseph JM, Aben KK, Anton-Culver H, Antonenkova N, Baker H, Bean Y, Beckmann MW, Bisogna M, Bjorge L, Bogdanova N, Brinton LA, Brooks-Wilson A, Bruinsma F, Butzow R, Campbell IG, Carty K, Cook LS, Cramer DW, Cybulski C, Dansonka-Mieszkowska A, Dennis J, Despierre E, Dicks E, Doherty JA, du Bois A, Dürst M, Easton D, Eccles D, Edwards RP, Ekici AB, Fasching PA, Fridley BL, Gao YT, Gentry-Maharaj A, Giles GG, Glasspool R, Gronwald J, Harrington P, Harter P, Hasmad HN, Hein A, Heitz F, Hildebrandt MA, Hogdall C, Hogdall E, Hosono S, Iversen ES, Jakubowska A, Jensen A, Ji BT, Karlan BY, Kellar M, Kelley JL, Kiemeney LA, Klapdor R, Kolomeyevskaya N, Krakstad C, Kjaer SK, Kruszka B, Kupryjanczyk J, Lambrechts D, Lambrechts S, Le ND, Lee AW, Lele S, Leminen A, Lester J, Levine DA, Liang D, Lissowska J, Liu S, Lu K, Lubinski J, Lundvall L, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, McNeish I, Menon U, Moes-Sosnowska J, N… See abstract for full author list ➔ Hampras SS, et al. Among authors: harrington p. Oncotarget. 2016 Oct 25;7(43):69097-69110. doi: 10.18632/oncotarget.10215. Oncotarget. 2016. PMID: 27533245 Free PMC article.

2

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BA. Gayther SA, et al. Among authors: harrington pa. Nat Genet. 1995 Dec;11(4):428-33. doi: 10.1038/ng1295-428. Nat Genet. 1995. PMID: 7493024

3

Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group.

Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BA. Gayther SA, et al. Among authors: harrington p. Am J Hum Genet. 1996 Mar;58(3):451-6. Am J Hum Genet. 1996. PMID: 8644703 Free PMC article.

4

Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.

Foster KA, Harrington P, Kerr J, Russell P, DiCioccio RA, Scott IV, Jacobs I, Chenevix-Trench G, Ponder BA, Gayther SA. Foster KA, et al. Among authors: harrington p. Cancer Res. 1996 Aug 15;56(16):3622-5. Cancer Res. 1996. PMID: 8705994

5

Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.

Ramus SJ, Bobrow LG, Pharoah PD, Finnigan DS, Fishman A, Altaras M, Harrington PA, Gayther SA, Ponder BA, Friedman LS. Ramus SJ, et al. Among authors: harrington pa. Genes Chromosomes Cancer. 1999 Jun;25(2):91-6. doi: 10.1002/(sici)1098-2264(199906)25:2<91::aid-gcc3>3.0.co;2-5. Genes Chromosomes Cancer. 1999. PMID: 10337991

6

The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.

Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA. Gayther SA, et al. Among authors: harrington p. Am J Hum Genet. 1999 Oct;65(4):1021-9. doi: 10.1086/302583. Am J Hum Genet. 1999. PMID: 10486320 Free PMC article.

7

The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.

Gayther SA, de Foy KA, Harrington P, Pharoah P, Dunsmuir WD, Edwards SM, Gillett C, Ardern-Jones A, Dearnaley DP, Easton DF, Ford D, Shearer RJ, Kirby RS, Dowe AL, Kelly J, Stratton MR, Ponder BA, Barnes D, Eeles RA. Gayther SA, et al. Among authors: harrington p. Cancer Res. 2000 Aug 15;60(16):4513-8. Cancer Res. 2000. PMID: 10969800

8

BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.

Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA. Ramus SJ, et al. Among authors: harrington p. Cancer Res. 2003 Jan 15;63(2):417-23. Cancer Res. 2003. PMID: 12543797

9

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.

Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS. Werness BA, et al. Among authors: harrington p. Int J Gynecol Pathol. 2004 Jan;23(1):29-34. doi: 10.1097/01.pgp.0000101083.35393.cd. Int J Gynecol Pathol. 2004. PMID: 14668547

10

Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival.

Abraham JE, Harrington P, Driver KE, Tyrer J, Easton DF, Dunning AM, Pharoah PD. Abraham JE, et al. Among authors: harrington p. Clin Cancer Res. 2009 Mar 15;15(6):2181-91. doi: 10.1158/1078-0432.CCR-08-0716. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page